360sek
-2,3 %
Date:2026-05-18Time:18:00:00Latest report:Q1-2026List:First NorthTicker:NANEXA
Market Cap:665 msekEnterprise Value:593 msekNet Sales:32,7 msekEarnings:-23,1 msekEmployees:0ISIN:SE0007074166

Ratios

10-year key figure history for Nanexa turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanexa with index and moving average MA50 and MA200.

Stockprice:3,60
MA50:3,74
MA200:2,92
Price/MA200:23,5 %
RSI (14):47,6
Price/MA50:-3,7 %

Description

Nanexa is a drug delivery company with a proprietary platform used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The company's technology is based on encapsulating drug particles with a thin shell and creating opportunities for pharmaceutical companies to develop new products. Nanexa has collaborations with several pharmaceutical companies, mainly around the Nordic market.

Medical Equipment